bronzewheel02

About

Look at usefulness and also basic safety associated with rituximab together with mycophenolate mofetil in sufferers together with nonspecific interstitial pneumonia non-responding into a first-line immunosuppressive remedy (EVER-ILD): A double-blind placebo-controlled randomized trial.